NECTAR
Research type
Research Study
Full title
Neurofeedback Treatment for Nociplastic Pain in Rheumatoid Arthritis
IRAS ID
330988
Contact name
Aleksandra Vuckovic
Contact email
Sponsor organisation
NHS Greater Glasgow & Clyde
Duration of Study in the UK
1 years, 4 months, 31 days
Research summary
Rheumatoid arthritis is caused an autoimmune condition, causing inflammation and pain. Yet pain may persist even when inflammation has been treated. This residual pain, called nociplastic pain, has symptoms of chronic pain condition called fibromyalgia. There are few effective therapies to address this residual pain. Published literature shows that fibromyalgia can be treated by neurofeedback, a noninvasive method that is based on the voluntary modulation of cortical activity. In this pilot study, we want to test the effect of neurofeedback, on the fibromyalgia component of pain in rheumatoid arthritis, and also to investigate its effects on related symptoms such as fatigue and sleep disturbance.
REC name
South East Scotland REC 01
REC reference
23/SS/0115
Date of REC Opinion
15 Jan 2024
REC opinion
Further Information Favourable Opinion